domingo, 27 de noviembre de 2016

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia. - PubMed - NCBI

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia. - PubMed - NCBI

 2016 Oct - Dec;38(4):346-357. doi: 10.1016/j.bjhh.2016.07.004. Epub 2016 Aug 20.

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia.

Abstract

Chronic lymphocytic leukemia is characterized by clonal proliferation and progressive accumulation of B-cell lymphocytes that typically express CD19+, CD5+ and CD23+. The lymphocytes usually infiltrate the bone marrow, peripheral blood, lymph nodes, and spleen. The diagnosis is established by immunophenotyping circulating B-lymphocytes, and prognosis is defined by two staging systems (Rai and Binet) established by physical examination and blood counts, as well as by several biological and genetic markers. In this update, we present the recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia for the diagnosis and treatment of chronic lymphocytic leukemia. The following recommendations are based on an extensive literature review with the aim of contributing to more uniform patient care in Brazil and possibly in other countries with a similar social-economic profile.

KEYWORDS:

Chronic lymphocytic leukemia; Cytogenetics; Immunophenotyping; Prognosis; Staging
PMID:
 
27863764
 
DOI:
 
10.1016/j.bjhh.2016.07.004
[PubMed - in process] 
Free full text

No hay comentarios:

Publicar un comentario en la entrada